National Center for Advancing Translational Sciences in Texas
National Center for Advancing Translational Sciences (93.350) awarded $167 million to recipients in Texas in 52 grants from fiscal 2021 to 2025, 5.4% of the program's national total. The University of Texas Southwestern Medical Center received the most, $45.3 million.
- Awarded in Texas$167 million
- Awards52
- Share of the program5.4%
- Rank among states6th of 41
- National total$3.1 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 20 | $34.7 million |
| FY 2022 | 21 | $29.6 million |
| FY 2023 | 19 | $27.7 million |
| FY 2024 | 27 | $38.6 million |
| FY 2025 | 26 | $36.2 million |
Recipients in Texas
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The University of Texas Southwestern Medical Center | Colleges and universities | 2 | $45.3 million |
| University of Texas Health Science Center at Houston | Colleges and universities | 11 | $33.4 million |
| The University of Texas Health Science Center at San Antonio | Colleges and universities | 8 | $30.0 million |
| University of Texas Medical Branch at Galveston | Colleges and universities | 7 | $26.0 million |
| Baylor College of Medicine | Colleges and universities | 9 | $20.8 million |
| Cellchorus Inc | Small businesses | 2 | $2.8 million |
| Texas A&m Engineering Experiment Station | Colleges and universities | 2 | $2.1 million |
| Atomo, Inc. | Small businesses | 1 | $1.9 million |
| Voxeleron Inc | Small businesses | 1 | $1.6 million |
| University of Texas at Austin | Colleges and universities | 2 | $596,511 |
Open opportunities under this program
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed)
- Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- Clinical and Translational Science Award (UM1 Clinical Trial Optional)
- Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)
See all 34 on the program page
Questions people ask
How much National Center for Advancing Translational Sciences money goes to Texas?
$167 million from fiscal 2021 to 2025, across 52 awards. Texas ranks 6th of 41 states and territories for this program.
Who receives National Center for Advancing Translational Sciences money in Texas?
The largest recipient is The University of Texas Southwestern Medical Center, with $45.3 million in 2 awards. Next are University of Texas Health Science Center at Houston and The University of Texas Health Science Center at San Antonio.
Can organizations in Texas apply now?
Yes, 34 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
National Center for Advancing Translational Sciences in other states
Other large programs in Texas
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Unaccompanied Alien Children Program
- Special Education Grants to States
- Community Development Block Grants/State's program and Non-Entitlement Grants in Hawaii